Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


March 30, 2015 6:44 AM ET

Biotechnology

Company Overview of Durata Therapeutics, Inc.

Executive Profile

Lisa M. Giles

Non-Executive Director and Member of Audit Committee, GenMark Diagnostics, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships
55--

Background

Ms. Lisa M. Giles is the Founder of Giles & Associates Consultancy, Inc. (“GAC”). Ms. Giles has been the President and Chief Executive Officer of Giles & Associates Consultancy, Inc. since 2000, and has been Chief Executive Officer of Optivara, Inc. since 2013. Ms. Giles served as Vice President of Strategy Development for Monsanto’s Pharmaceutical Division at G.D. Searle & Company, where she was instrumental in the creation of Searle’s transformation strategy and directing ...

Corporate Headquarters

200 Sourth Wacker Drive
Chicago, Illinois 60606

United States

Phone: 312-219-7000
Fax: --

Board Members Memberships

2005-N/A
Former Director
2012-Present
Director and Member of Audit Committee
2015-Present
Non-Executive Director and Member of Audit Committee

Education

BS
Juniata College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John L. Bishop Chairman, Chief Executive Officer and Member of Equity Incentive Committee
Cepheid
$664.9K
Peer M. Schatz Chairman of Management Board, Chief Executive Officer and Managing Director
Qiagen NV
$1.9M
Douglas C. Bryant Chief Executive Officer, President and Director
Quidel Corp.
$509.1K
Nachum Shamir Chief Executive Officer and President
Luminex Corporation
--
Alexandre Merieux Chief Executive Officer, Director and Member of Strategy Committee
bioMérieux SA
$544.9K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Durata Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.